Torlone, E <br/><br/>
Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM.  [electronic resource] 

 -  Diabetologia  Jul 1994 
 - 713-20 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0012-186X 
<br/><br/><label>Standard No.: </label>10.1007/BF00417697  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Blood Glucose--analysis<br/>Cognition--physiology<br/>Diabetes Mellitus, Type 1--complications<br/>Female<br/>Glucose--metabolism<br/>Humans<br/>Hypoglycemia--chemically induced<br/>Hypoglycemic Agents--pharmacokinetics<br/>Infusions, Intravenous<br/>Injections, Subcutaneous<br/>Insulin--analogs & derivatives<br/>Insulin Lispro<br/>Liver--metabolism<br/>Male